Plain-English translation of NCT07186556 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a program called RISE-YA, which delivers supervised exercise sessions remotely to young adults (ages 18–39) who have completed brain tumor treatment and are experiencing fatigue. The program aims to reduce cancer-related fatigue, improve physical fitness, and help your body recover strength after treatment. Researchers will also look at how exercise affects inflammation and energy production in your cells.
Many young brain tumor survivors struggle with ongoing fatigue after finishing treatment, which can affect their quality of life and ability to return to daily activities. This study exists to see whether a guided, at-home exercise program can help reduce that fatigue and restore physical strength and function.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the RISE-YA remote exercise program or to a comparison group. Participants in the exercise program will participate in supervised workouts delivered online, guided by a trainer, along with assessments of your fatigue, fitness, muscle strength, and overall quality of life. The study involves baseline testing, regular exercise sessions over several weeks, and follow-up measurements to see how the program affects your fatigue and physical function.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Collaborators
Cancer Prevention Research Institute of Texas
Enrollment target
~75 participants
Started
September 2025
Primary completion
December 2029
Age range
18 Years – 39 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Michael Roth, MD
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.